ARS Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard E. Lowenthal, with a market cap of $811.3M.
Based on Q1 2026 filing
Common questions about ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. (SPRY) has a market capitalization of $811.3M and trades on NASDAQ.
ARS Pharmaceuticals, Inc. has approximately 24 employees.